RSV-M-203: Study M-203 - A Phase II Randomized, Observer-blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) Fusion (F)
Clinical Trial Grant
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Novavax, Inc.
Start Date
October 1, 2014
End Date
May 15, 2017
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Novavax, Inc.
Start Date
October 1, 2014
End Date
May 15, 2017